The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Комплексная молекулярная характеристика почечно-клеточной карциномы в рамках The Cancer Genome Atlas
2018-04-01
SCID: 54.1/zua3xcbv
Discuss with AI
BAP1 PBRM1 PTEN alterationsCIMP-RCCThe Cancer Genome Atlasmolecular characterizationrenal cell carcinoma
Figures from the paper
Abstract (AI)
Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and therapeutic responses. The current study evaluated 843 RCC from the three major histologic subtypes, including 488 clear cell RCC, 274 papillary RCC, and 81 chromophobe RCC. Comprehensive genomic and phenotypic analysis of the RCC subtypes reveals distinctive features of each subtype that provide the foundation for the development of subtype-specific therapeutic and management strategies for patients affected with these cancers. Somatic alteration of BAP1, PBRM1, and PTEN and altered metabolic pathways correlated with subtype-specific decreased survival, while CDKN2A alteration, increased DNA hypermethylation, and increases in the immune-related Th2 gene expression signature correlated with decreased survival within all major histologic subtypes. CIMP-RCC demonstrated an increased immune signature, and a uniform and distinct metabolic expression pattern identified a subset of metabolically divergent (MD) ChRCC that associated with extremely poor survival.
Key Findings
1
Alterations in BAP1, PBRM1, and PTEN, together with disrupted metabolic pathways, correlated with decreased survival in specific RCC subtypes.
2
CDKN2A alteration, increased DNA hypermethylation, and stronger immune-related Th2 gene-expression signatures correlated with decreased survival across all major RCC subtypes.
3
CIMP-RCC showed increased immune signatures, while a metabolically divergent chromophobe RCC subgroup exhibited a distinct metabolic pattern and extremely poor survival.
4
Each RCC subtype displayed distinctive genomic, phenotypic, and metabolic features, supporting subtype-specific therapeutic and clinical management strategies.
5
The study comprehensively characterized 843 renal cell carcinomas across clear cell, papillary, and chromophobe histologic subtypes.
Research Object
Renal cell carcinoma (RCC), comprising clear cell, papillary, and chromophobe histologic subtypes
Research Subject
Distinctive genomic, epigenetic, metabolic, immune, phenotypic, and survival characteristics of RCC subtypes and their associations with patient outcomes
Publication Details
Publication Date
2018-04-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest